FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 107 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $4,185,000 | +139.6% | 102,289 | +76.3% | 0.01% | +140.0% |
Q2 2017 | $1,747,000 | -18.1% | 58,029 | -1.7% | 0.01% | -16.7% |
Q1 2017 | $2,133,000 | -62.8% | 59,008 | -48.4% | 0.01% | -64.7% |
Q4 2016 | $5,732,000 | -3.4% | 114,397 | +1.2% | 0.02% | -5.6% |
Q3 2016 | $5,934,000 | -26.9% | 113,062 | -42.4% | 0.02% | -28.0% |
Q2 2016 | $8,119,000 | +23.9% | 196,350 | +21.7% | 0.02% | +19.0% |
Q1 2016 | $6,555,000 | +3.6% | 161,355 | +5.9% | 0.02% | +10.5% |
Q4 2015 | $6,326,000 | +172.7% | 152,426 | +1.1% | 0.02% | +171.4% |
Q3 2015 | $2,320,000 | -66.1% | 150,773 | -45.3% | 0.01% | -61.1% |
Q2 2015 | $6,852,000 | – | 275,866 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |